ArticleKidney international reports2026
Multiplexed Detection of Membranous Nephropathy Antigens by Multi-Reaction Monitoring Mass Spectrometry.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Membranous nephropathy (MN) is a leading cause of nephrotic syndrome, driven by an immune response against a target autoantigen. To date, over 30 target antigens have been described in MN, creating the need for multiplex approaches. We developed a multiple reaction monitoring (MRM)-based assay for the clinical mass spectrometry (MS) laboratory for determination of an antigen type in nephropathology practice. Here, we provide detailed methods and validation data to ensure adaptability among different instruments and laboratories. Methods: Protein A/G immunoprecipitation was used to extract immune complexes from frozen kidney biopsy tissue. Proteins were eluted from magnetic beads, reduced, alkylated, and trypsin digested using single-pot, solid-phase-enhanced sample preparation workflow. Tryptic peptide quantities were measured by MS with internal standard (IS) peptides. Peak area ratios were used to call an antigen type. Immunostaining was used as an independent method to confirm target antigen types. A calling algorithm was empirically developed that maximizes sensitivity and specificity of the workflow for identifying membranous antigens in kidney biopsies. Results: Our immunoprecipitation-to-MS workflow demonstrated reliable quantitative detection of a total of 19 MN antigens. The MS-enabled workflow had a diagnostic accuracy of 97.2% with a sensitivity of 97.2% and 100% specificity from a validation cohort of 113 MN cases with antigen type confirmed by immunostaining. Conclusion: MRM-MS following protein A/G immunoprecipitation of MN biopsy tissue can be effectively used for multiplex antigen typing in clinical nephropathology practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.